1 Product identity
Ingredient risk
1 ingredient to use with caution
K-MG
BrandAdvanced Research→Mineral Tablet or Pill 9 ingredients 1 caution DSLD #273586Net contents: 200 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2023-03-22
2 Ingredients (9)
IngredientGroupSafety
Microcrystalline CelluloseCellulose—
PovidonePovidone—
Cellulose GumCellulose—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Potassium — Conditionally Safe
⚠ Hyperkalemia risk
⚠ Dangerous with ACE inhibitors
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
4 Label claims
• All Other
5 Data source
DSLD ID273586
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2023-03-22
6 More from Advanced Research
View Advanced Research Safety Scorecard → 2 products
Zinc Orotate 60 mg7 Cite this page
Vancouver
Pkhakadze G. K-MG — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 07]. Available from: https://supplement.ge/products/dsld-273586/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG